Descriptors
Documents disponibles dans cette catégorie (2)
Add the result to your basket Make a suggestion Refine your search Apply to external sources
Extend search on down-posting(s)
Pneumococcal serotypes in children in 4 European countries / Germaine Hanquet in Emerging Infectious Diseases, 16(2010)09 ([09/01/2010])
[article] Pneumococcal serotypes in children in 4 European countries [printed text] / Germaine Hanquet, Author ; Esther Kissling, Author ; Asuncion Fenoll, Author ; Robert George, Author ; Agnes Lepoutre, Author ; Tinne Lernout, Author ; David Tarrago, Author ; Emmanuelle Varon, Author ; J. Verhaegen, Author . - 2010 . - 1428-39.
Languages : English (eng)
in Emerging Infectious Diseases > 16(2010)09 [09/01/2010] . - 1428-39
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Adolescent ; Belgium ; Child ; Child, Preschool ; Female ; France ; Great Britain ; Humans ; Infant ; Infant, Newborn ; Journal Article ; Male ; Meningitis, Pneumococcal ; Peer Review ; Pneumococcal Infections ; Pneumococcal Vaccines ; Prospective Studies ; Spain ; Time Factors ; United StatesAbstract: After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 serotypes (NVT) increased. Adjusted serotype-specific incidences among children <15 years of age were compared between 1999-2002 (prevaccine) and 2005-2006 (postmarketing). Vaccine coverage increased to approximately 32%-48% in France, Spain, and Belgium but remained <1% in England and Wales. Serotype 1 incidence rose in all age groups and countries (incidence rate ratio [IRR] 1.3-4.2; p<0.004), independently of PCV7 use, but incidence of serotypes 7F and 19A increased most in France, Spain, and Belgium (IRR 1.9-16.9 in children <5 years; p<0.001), where PCV7 coverage was greater. Vaccine-induced replacement of PCV7 serotypes possibly contributed to NVT increases, as did secular trends. New vaccines targeting these serotypes are available, but serotype dynamics needs further exploration that accounts for underreporting and prevaccine trends. Link for e-copy: http://www.cdc.gov/eid/content/16/9/pdfs/1428.pdf Format of e-copy: PDF [Open Access] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2361 [article]Surveillance of invasive pneumococcal disease in 30 EU countries / Germaine Hanquet in Vaccine, 28(2010)23 ([05/21/2010])
[article] Surveillance of invasive pneumococcal disease in 30 EU countries : Towards a European system? [printed text] / Germaine Hanquet, Author ; A. Perrocheau, Author ; Esther Kissling, Author ; D.L. Bruhl,, Author ; David Tarrago, Author ; J. Stuart, Author ; P. Stefanoff, Author ; S. Heuberger, Author ; P. Kriz, Author ; A. Vergison, Author ; S.C. de Greeff, Author ; A. Amato-Gauci, Author ; L.P. Celentano, Author . - 2010 . - 3920-8.
Languages : English (eng)
in Vaccine > 28(2010)23 [05/21/2010] . - 3920-8
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Disease Notification ; Europe ; Humans ; Immunization Programs ; Incidence ; Journal Article ; Meningitis, Pneumococcal ; Netherlands ; Peer Review ; Pneumococcal Infections ; Pneumococcal Vaccines ; Population Surveillance ; Vaccines ConjugateAbstract: In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance. We confirmed the heterogeneity of surveillance systems and case definitions across countries but identified elements common to all countries, such as the availability of serotyping and the surveillance of pneumococcal meningitis. PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced. Link for e-copy: http://tiny.cc/rxh20 Format of e-copy: VDIC IP recognition Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2371 [article]